The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ikonnikova E.V.

Federal State Institution of Additional Postgraduate Education «Central State Medical Academy» of Affairs Administration of the President of the Russian Federation, Moscow, Russia

Sten'ko A.G.

OOO "Institut plasticheskoĭ khirurgii i kosmetologii"

Chajkovskaya E.A.

Institute of Plastic Surgery and Cosmetology, Moscow, Russia

Zmazova V.G.

OAO "Institut plasticheskoĭ khirurgii i kosmetologii", Moskva

Complication of non-surgical rhinoplasty

Authors:

Ikonnikova E.V., Sten'ko A.G., Chajkovskaya E.A., Zmazova V.G.

More about the authors

Read: 23624 times


To cite this article:

Ikonnikova EV, Sten'ko AG, Chajkovskaya EA, Zmazova VG. Complication of non-surgical rhinoplasty. Plastic Surgery and Aesthetic Medicine. 2019;(4):76‑81. (In Russ.)
https://doi.org/10.17116/plast.hirurgia201904176

Recommended articles:
Features of perioperative period in patients with cardiovascular-kidney-metabolic syndrome. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):26-33

References:

  1. Site G, Manzoni V, Sommariva R. Vascular Complications after facial filler injection: a literature review and metaanalysis. J Clin Aesthet Dermatol. 2019;12(6):65-72.
  2. Urdiales-Gálvez F, Delgado NE, Figueiredo V, Lajo-Plaza JV, Mira M, Moreno A, Ortíz-Martí F, Del Rio-Reyes R, Romero-Álvarez N, Del Cueto SR, Segurado MA, Rebenaque CV. Treatment of soft tissue filler complications: expert consensus recommendations. Aesthetic Plast Surg. 2018;42(2):498-510.
  3. De Lorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J. 2014;1-34(4):584-600. https://doi.org/10.1177/1090820X14525035
  4. Yutskovskaya Y, Kogan E, Leshunov E. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. J Drugs Dermatol. 2014;13(9):1047-1052.
  5. Alekhina SP, Shcerbatyuk TG. Ozonoterapiya: klinichesie i eksperimental’nye aspekty. Sarov; FGUPRFYaC-VNIIEF, 2004. (In Russ.)
  6. Kosheleva IV, Simonova AV. Kislorodno-ozonovaya terapiya immunozavisimyh dermatozov. Fizioterapiya, bal’enologiya i reabilitaciya. 2013;2:14-20. (In Russ.)
  7. Kosheleva IV. Primenenie ozonokislorodnoj smesi v dermatologii I lechebnoj kosmetologii. Kosmetika i meditsina. 2000;4:68-75. (In Russ.)
  8. Rayess HM, Svider PF, Hanba C, Patel VS, De Joseph LM, Carron M, Zuliani GF. A Cross-sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg. 2018;20(3):207-214.
  9. Sung MS, Kim HG, Woo KI, Kim YD. Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler. Ophthalmic Plast Reconstr Surg. 2010;26(4):289-291.
  10. Chou CC, Chen HH, Tsai YY, Li YL, Lin HJ. Choroid vascular occlusion and ischemic optic neuropathy after facial calcium hydroxya patitent jection — a case report. BMC Surg. 2015;8(15):21.
  11. Hsiao SF, Huang YH. Partial vision recovery after iatrogenic retinal artery occlusion. BMC Ophthalmol. 2014;11(14):120. https://doi.org/10.1186/1471-2415-14-120
  12. Dagi Glass LR, Choi CJ, Lee NG. Orbital Complication Following Calcium Hydroxylapatite Filler Injection. Ophthalmic Plast Reconstr Surg. 2017;33:16-17. https://doi.org/10.1097/IOP.0000000000000584
  13. Cohen E, Yatziv Y, Leibovitch I, Kesler A, Cnaan RB, Klein A, Goldenberg D, Habot-Wilner Z. A case report of ophthalmic artery emboli secondary to Calcium Hydroxylapatite filler injection for nose augmentation — long-term outcome. BMC Ophthalmol. 2016;8(16):98. https://doi.org/10.1186/s12886-016-0276-3
  14. Tracy L, Ridgway J, Nelson JS, Lowe N, Wong B. Calcium hydroxylapatite associated soft tissue necrosis: a case report and treatment guideline. J Plast Reconstr Aesthet Surg. 2014;67(4):564-568. https://doi.org/10.1016/j.bjps.2013.08.008
  15. Beer K, Downie J, Beer J. A treatment protocol for vascular occlusion from particulate soft tissue augmentation. J Clin Aesthet Dermatol. 2012;5(5):44-47.
  16. Yutskovskaya YaA, Kislitsyna AI, Baybarina EV, Ter-Ter’yan EG, Zabroda KV, Turkevich AYu, et al. Gialuronidaza: opyt lecheniya oslozhnenij posle vvedeniya fillerov. Inekcionnye metody v kosmetologii. 2019;2:4-17. (In Russ.)
  17. Uittenbogaard D, Lansdorp CA, Bauland CG, Boonstra O. Hyperbaric oxygen therapy for dermal ischemia after dermal filler injection with calcium hydroxylapatite: a case report. Undersea Hyperb Med. 2019;46(2):207-210.
  18. Souza Felix Bravo B, Klotz De Almeida Balassiano L, Roos Mariano Da Rocha C, Barbosa De Sousa Padilha C, Martinezt Torrado C, Teixeira Da Silva R, Regazzi Avelleira JC. Delayed-type necrosis after soft-tissue augmentation with hyaluronic acid. J Clin Aesthet Dermatol. 2015;8(12):42-47.
  19. Pilsl U, Anderhuber F. The external nose: the nasal arteries and their course in relation to the nasolabial fold and groove. Plast Reconstr Surg. 2016;138(5):830-835.
  20. Saban Y, Andretto Amodeo C, Bouaziz D, Polselli R. Nasal arterial vasculature: medical and surgical applications. Arch Facial Plast Surg. 2012;14(6):429-436. https://doi.org/10.1001/archfacial.2012.202
  21. Rayess HM, Svider PF, Hanba C, Patel VS, DeJoseph LM, Carron M1, Zuliani GF. A cross-sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg. 2018;20(3):207-214. https://doi.org/10.1001/jamafacial.2017.1888
  22. Goodman GJ, Roberts S, Callan P. Experience and management of intravascular injection with facial fillers: results of a multinational survey of experienced injectors. Aesthetic Plast Surg.2016;40(4):549-555. https://doi.org/10.1007/s00266-016-0658-1
  23. Sung HM, Suh IS, Lee HB, Tak KS, Moon KM, Jung MS. Case reports of adipose-derived stem cell therapy for nasal skin necrosis after filler injection. Arch Plast Surg. 2012;(39)1:51-54. https://doi.org/10.5999/aps.2012.39.1.51
  24. Robinson DM. In vitro analysis of the degradation of calcium hydroxylapatite dermal filler: a proof-of-concept study. Dermatol Surg. 2018;(44)1:5-9. https://doi.org/10.1097/DSS.0000000000001683
  25. Kreymereman P, Miller W. Sodium thiosulfate injection dissolves calcium hydroxylapatite particles: an animal study. J Am Acad Dermatol. 2018;79(3)1: AB265.
  26. Robinson D. Dissolving calcium hydroxylapatite filler with the use of sodium thiosulfate: a proof-of-concept clinical study. J Am Acad Dermatol. 2018; 79(3)1:AB111.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.